Hepatitis b, chronic Trials in Guangzhou, China
Conditions / Hepatitis b, chronic / Guangzhou, China
Clinical trials for Hepatitis b, chronic investigate a range of treatment strategies and patient populations.
45 total trials for this combination
Showing top 10 of 45 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01011738 | An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys | COMPLETED | — |
| NCT04225715 | A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B | COMPLETED | PHASE2 |
| NCT00435825 | A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB). | COMPLETED | PHASE4 |
| NCT05630820 | Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01855997 | A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue | COMPLETED | — |
| NCT01519960 | A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B | COMPLETED | PHASE3 |
| NCT00927082 | A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B | COMPLETED | PHASE4 |
| NCT03982186 | A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection | COMPLETED | PHASE2 |
| NCT05630807 | Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01730508 | An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B | COMPLETED | — |